Basic Information

Terpenoid ID TKC206784
Chirality TKC113177
Cell line 0
Protein target 13
DiseaseNCIT 0
ORDO 0
ICD 30

Active subnetwork


Terpenoid-cell-disease Activity Association

ID Cell Line Synonyms Value Unit Type NCIt ORDO

Terpenoid-protein target Activity Association

ID Uniport Pref_name Gene name value unit type
TKC206784 P10636 Microtubule-associated protein tau MAPT 15849 nM Potency
TKC206784 Q16637 Survival motor neuron protein SMN1,SMN2 15849 nM Potency
TKC206784 Q16637 Survival motor neuron protein SMN1,SMN2 15849 nM Potency
TKC206784 O95398 Rap guanine nucleotide exchange factor 3 RAPGEF3 50119 nM Potency
TKC206784 Q03431 Parathyroid hormone/parathyroid hormone-related peptide receptor PTH1R 6310 nM Potency
TKC206784 Q16236 Nuclear factor erythroid 2-related factor 2 NFE2L2 20596 nM Potency
TKC206784 O75496 Geminin GMNN 6513 nM Potency
TKC206784 Q13148 TAR DNA-binding protein 43 TARDBP 5623 nM Potency
TKC206784 P83916 Chromobox protein homolog 1 CBX1 100000 nM Potency
TKC206784 Q96KQ7 Histone-lysine N-methyltransferase EHMT2 EHMT2 56234 nM Potency
TKC206784 Q96QE3 ATPase family AAA domain-containing protein 5 ATAD5 20596 nM Potency
TKC206784 B2RXH2 Lysine-specific demethylase 4E KDM4E 39811 nM Potency
TKC206784 Q9NR56 Muscleblind-like protein 1 MBNL1 7080 nM Potency
TKC206784 Q194T2 Non-structural protein 1 NS1 4467 nM Potency
TKC206784 Q8IL88 HSP40, subfamily A PF3D7_1437900 7 uM AbsAC1000_uM
TKC206784 P38889 Transcription factor SKN7 SKN7 2 uM AbsAC40_uM

Protein target-disease Activity Association

Uniport ID Uniport Name ICD-11
P10636 TAU_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
P10636 TAU_HUMAN Alzheimer disease [ICD-11: 8A20]
P10636 TAU_HUMAN Mild neurocognitive disorder [ICD-11: 6D71]
P10636 TAU_HUMAN Choreiform disorder [ICD-11: 8A01]
P10636 TAU_HUMAN Parkinsonism [ICD-11: 8A00]
P10636 TAU_HUMAN Central nervous system disease [ICD-11: 8A04-8D87]
P10636 TAU_HUMAN Neurodegenerative disorder [ICD-11: 8A20-8A23]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
Q16637 SMN_HUMAN Muscular atrophy [ICD-11: 8B61]
O95398 RPGF3_HUMAN Epidermal dysplasias [ICD-11: EK90]
Q03431 PTH1R_HUMAN Low bone mass disorder [ICD-11: FB83]
Q03431 PTH1R_HUMAN Hypo-parathyroidism [ICD-11: 5A50]
Q16236 NF2L2_HUMAN Ataxic disorder [ICD-11: 8A03]
Q16236 NF2L2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q16236 NF2L2_HUMAN Glaucoma [ICD-11: 9C61]
Q16236 NF2L2_HUMAN Lung cancer [ICD-11: 2C25]
Q16236 NF2L2_HUMAN Macular degeneration [ICD-11: 9B75]
Q16236 NF2L2_HUMAN Melanoma [ICD-11: 2C30]
Q16236 NF2L2_HUMAN Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z]
Q16236 NF2L2_HUMAN Pulmonary hypertension [ICD-11: BB01]
Q16236 NF2L2_HUMAN Subarachnoid haemorrhage [ICD-11: 8B01]
Q16236 NF2L2_HUMAN Urinary system clinical sympton [ICD-11: MF8Y]
Q16236 NF2L2_HUMAN Non-alcoholic fatty liver disease [ICD-11: DB92]
Q16236 NF2L2_HUMAN Alpha-1-antitrypsin deficiency [ICD-11: 5C5A]
Q16236 NF2L2_HUMAN Motor neuron disease [ICD-11: 8B60]
Q16236 NF2L2_HUMAN Multiple sclerosis [ICD-11: 8A40]
Q13148 TADBP_HUMAN Acute myeloid leukaemia [ICD-11: 2A60]
Q13148 TADBP_HUMAN Alzheimer disease [ICD-11: 8A20]
Q96KQ7 EHMT2_HUMAN Breast cancer [ICD-11: 2C60-2C6Y]
Q96KQ7 EHMT2_HUMAN Postoperative inflammation [ICD-11: 1A00-CA43]
Q96KQ7 EHMT2_HUMAN Solid tumour/cancer [ICD-11: 2A00-2F9Z]